Cancer immunotherapy Benefit and harm?

被引：3
|
作者：
Characiejus, Dainius [1 ]
机构：
[1] Vilnius Univ, Fac Med, Vilnius, Lithuania
来源：
ONCOIMMUNOLOGY | 2012年 / 1卷 / 02期
关键词：
cancer; immunotherapy; prediction; survival; CD8; CD57; RENAL-CELL-CARCINOMA; INTERFERON-ALPHA; MELANOMA; THERAPY;
D O I：
10.4161/onci.1.2.18183
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
In this article, evidence is reviewed suggesting that the outcome of cancer immunotherapy depends on pre-treatment immune parameters of a patient. The results described in the article show that immunotherapy may prolong survival in certain subgroups of cancer patients, while in other subgroups a cancer-promoting effect of this treatment modality cannot be excluded.
引用
收藏
页码：232 / 233
页数：2
相关论文
共 50 条
  • [1] Antioxidants in cancer therapy: harm or benefit?
    Biesalski, H. K.
    [J]. ONKOLOGIE, 2011, 34 : 303 - 303
  • [2] Breast Cancer Screening: Benefit or Harm?
    Jorgensen, Karsten Juhl
    Gotzsche, Peter C.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2016, 315 (13): : 1402 - 1402
  • [3] BIOMARKERS FOR MONITORING OVARIAN CANCER: BENEFIT OR HARM?
    Marth, C.
    [J]. TUMOR BIOLOGY, 2010, 31 : S23 - S23
  • [4] Benefit and harm associated with screening for breast cancer
    Sox, HC
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1998, 338 (16): : 1145 - 1146
  • [5] Multidisciplinary care for cancer patients - harm or benefit?
    Ewert, J.
    Luhmann, M.
    Hermann, L.
    Reich, U.
    Mehnert, A.
    de, Wit M.
    [J]. ONKOLOGIE, 2011, 34 : 227 - 227
  • [6] Anesthetic technique for cancer surgery: Harm or benefit for cancer recurrence?
    Kim, R.
    [J]. EJSO, 2018, 44 (05): : 557 - 558
  • [7] BENEFIT AND HARM
    BENDITT, TM
    [J]. PHILOSOPHY AND PHENOMENOLOGICAL RESEARCH, 1976, 37 (01) : 116 - 120
  • [8] MRI in breast cancer management: Potential for benefit and harm
    Jatoi, I
    [J]. INTERNATIONAL JOURNAL OF FERTILITY AND WOMENS MEDICINE, 2005, 50 (06): : 281 - 284
  • [9] Is There a Benefit of Combining Immunotherapy and Radiotherapy in Bladder Cancer?
    Wilkins, A.
    Ost, P.
    Sundahl, N.
    [J]. CLINICAL ONCOLOGY, 2021, 33 (06) : 407 - 414
  • [10] Polypharmacy: Benefit or harm?
    Guomundsson, Aoalsteinn
    [J]. LAEKNABLADID, 2023, 109 (10): : 435 - 435
12345